Efficient Payload Delivery by a Bispecific Antibody–Drug Conjugate Targeting HER2 and CD63

结合 抗体-药物偶联物 药品 有效载荷(计算) 抗体 双特异性抗体 病毒学 药物输送 药理学 计算生物学 医学 单克隆抗体 生物 化学 免疫学 计算机科学 计算机安全 数学 数学分析 网络数据包 有机化学
作者
Bart E.C.G. de Goeij,Tom Vink,Hendrik ten Napel,Esther C.W. Breij,David P. E. Satijn,Richard Wubbolts,David Miao,Paul W.H.I. Parren
出处
期刊:Molecular Cancer Therapeutics [American Association for Cancer Research]
卷期号:15 (11): 2688-2697 被引量:138
标识
DOI:10.1158/1535-7163.mct-16-0364
摘要

Abstract Antibody–drug conjugates (ADC) are designed to be stable in circulation and to release potent cytotoxic drugs intracellularly following antigen-specific binding, uptake, and degradation in tumor cells. Efficient internalization and routing to lysosomes where proteolysis can take place is therefore essential. For many cell surface proteins and carbohydrate structures on tumor cells, however, the magnitude of these processes is insufficient to allow for an effective ADC approach. We hypothesized that we could overcome this limitation by enhancing lysosomal ADC delivery via a bispecific antibody (bsAb) approach, in which one binding domain would provide tumor specificity, whereas the other binding domain would facilitate targeting to the lysosomal compartment. We therefore designed a bsAb in which one binding arm specifically targeted CD63, a protein that is described to shuttle between the plasma membrane and intracellular compartments, and combined it in a bsAb with a HER2 binding arm, which was selected as model antigen for tumor-specific binding. The resulting bsHER2xCD63his demonstrated strong binding, internalization and lysosomal accumulation in HER2-positive tumor cells, and minimal internalization into HER2-negative cells. By conjugating bsHER2xCD63his to the microtubule-disrupting agent duostatin-3, we were able to demonstrate potent cytotoxicity of bsHER2xCD63his-ADC against HER2-positive tumors, which was not observed with monovalent HER2- and CD63-specific ADCs. Our data demonstrate, for the first time, that intracellular trafficking of ADCs can be improved using a bsAb approach that targets the lysosomal membrane protein CD63 and provide a rationale for the development of novel bsADCs that combine tumor-specific targeting with targeting of rapidly internalizing antigens. Mol Cancer Ther; 15(11); 2688–97. ©2016 AACR.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
3秒前
JamesPei的应助被十三月的萧邦采纳,获得10
3秒前
3秒前
深情安青的应助被小刘接好运采纳,获得10
3秒前
cchh完成签到,获得积分10
3秒前
蓝胖子完成签到 ,获得积分10
3秒前
酷波er的应助被8mian采纳,获得10
4秒前
4秒前
4秒前
马巧巧发布了新的文献求助30
4秒前
哈哈完成签到,获得积分20
4秒前
大模型的应助被Anben采纳,获得10
5秒前
852的应助被cwlm12采纳,获得10
5秒前
科研人完成签到 ,获得积分10
5秒前
蕾先生发布了新的文献求助10
5秒前
5秒前
5秒前
木木彡发布了新的文献求助10
7秒前
Maestro_S的应助被吱吱采纳,获得10
7秒前
業業发布了新的文献求助10
8秒前
偷猪雅贼完成签到,获得积分10
8秒前
zz完成签到 ,获得积分10
9秒前
9秒前
英俊的铭的应助被从容的半蕾采纳,获得10
10秒前
852的应助被植保匠人采纳,获得100
10秒前
京城落日发布了新的文献求助10
10秒前
Hello的应助被8mian采纳,获得10
10秒前
10秒前
sci发布了新的文献求助30
11秒前
打打的应助被Kyra采纳,获得10
11秒前
Anben完成签到,获得积分10
11秒前
沈大大完成签到,获得积分10
12秒前
xu完成签到,获得积分10
12秒前
搜集达人的应助被马踏飞鹰采纳,获得10
12秒前
12秒前
13秒前
13秒前
郗XI完成签到 ,获得积分10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188118
求助须知:如何正确求助?哪些是违规求助? 9575977
关于积分的说明 21844428
捐赠科研通 7785918
什么是DOI,文献DOI怎么找? 3435205
关于科研通互助平台的介绍 2559558
邀请新用户注册赠送积分活动 2482065